All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?

by Sofie Schaerlaekens, Lotte Jacobs, Kim Stobbelaar, Paul Cos, Peter Delputte
Published 2024-01-01

Subtractive Immunization as a Method to Develop Respiratory Syncytial Virus (RSV)—Specific Monoclonal Antibodies

by Lotte Jacobs, Kim Stobbelaar, Annick Heykers, Paul Cos, Peter Delputte
Published 2023-09-01

Isolation and Characterization of Clinical RSV Isolates in Belgium during the Winters of 2016–2018

by Winke Van der Gucht, Kim Stobbelaar, Matthias Govaerts, Thomas Mangodt, Cyril Barbezange, Annelies Leemans, Benedicte De Winter, Steven Van Gucht, Guy Caljon, Louis Maes, Jozef De Dooy, Philippe Jorens, Annemieke Smet, Paul Cos, Stijn Verhulst, Peter L. Delputte
Published 2019-11-01

Risk Factors Associated with Severe RSV Infection in Infants: What Is the Role of Viral Co-Infections?

by Kim Stobbelaar, Thomas C. Mangodt, Winke Van der Gucht, Lise Delhaise, Jasmine Andries, Valérie Gille, Cyril Barbezange, Annemieke Smet, Benedicte Y. De Winter, Jozef J. De Dooy, Tom Schepens, Els L. I. M. Duval, Paul Cos, Philippe G. Jorens, Stijn Verhulst, Peter L. Delputte
Published 2023-06-01